Kyowa Hakko Kirin Co Ltd (4151.T) Quote|
United States

Kyowa Hakko Kirin Co Ltd (4151.T)

4151.T on Tokyo Stock Exchange

30 Jun 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4151.T


Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of... (more)


Beta: 0.63
Market Cap(Mil.): ¥1,023,258.00
Shares Outstanding(Mil.): 576.48
Dividend: 12.50
Yield (%): 1.41


  4151.T Industry Sector
P/E (TTM): 29.85 34.76 35.71
EPS (TTM): 59.46 -- --
ROI: 5.22 15.00 14.23
ROE: 5.40 16.06 15.43

BRIEF-Medgenics enters collaboration with Kyowa Hakko Kirin

* Entered collaboration with Kyowa Hakko Kirin Co Ltd for development and commercialization of Kyowa Hakko's anti-light monoclonal antibody

Jun 06 2016

BRIEF-AstraZeneca to sell rights for constipation drug in Europe

* AstraZeneca enters into agreement with Prostrakan for rights to moventig in Europe

Mar 01 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : MarketLine
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.